Evaluation of the efficacy and safety of conversion from the tacrolimus capsule to tablet in stable liver transplant recipients with maintenance therapy: a 24-week, open-label, single-center, phase IV exploratory clinical study.
Jae-Yoon KimSukyoung ChangJi Young KimHyun Hwa ChoiJaewon LeeSu Young HongJeong-Moo LeeSuk Kyun HongYoung Rok ChoiNam-Joon YiKwang-Woong LeeKyung-Suk SuhPublished in: Annals of surgical treatment and research (2023)
The present study suggests that the new tablet formula can be a useful treatment option to maintain a consistent level of tacrolimus with a lower total daily dose and number in adult LT recipients.